Ginwa Enterprise GroupSHSE:600080 -1.20%47 Days Payable is 22.60 as of Mar. 2026, which is 62% below its 10-year median of 59.69. GuruFocus rates SHSE:600080 with a GF Score™ of 47/100 and a GF Value™ of ¥7.53 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 922 Drug Manufacturers companies, Ginwa Enterprise Group ranks worse than 55.42% on this metric.
The historical rank and industry rank for Ginwa Enterprise Group's Days Payable or its related term are showing as below:
SHSE:600080'
s Days Payable Range Over the Past 10 Years
Min: 39.21 Med: 59.69 Max: 85.82
Current: 81.44
During the past 13 years, Ginwa Enterprise Group's highest Days Payable was 85.82. The lowest was 39.21. And the median was 59.69.
SHSE:600080's Days Payable is ranked worse than 55.42% of 922
companies
in the Drug Manufacturers industry
Industry Median: 90.61
vs SHSE:600080: 81.44
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ginwa Enterprise Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ginwa Enterprise Group Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ginwa Enterprise Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Ginwa Enterprise Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Ginwa Enterprise Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ginwa Enterprise Group (SHSE:600080) has a Days Payable of 22.60 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ginwa Enterprise Group and its competitors. This is 62% below median its historical median of 59.69. Over the past decade, Ginwa Enterprise Group's Days Payable has ranged from 39.21 to 85.82. According to the industry distribution chart, Ginwa Enterprise Group ranks #511 out of 922 companies in the Drug Manufacturers industry, placing it in the top 55.4%.
Is Ginwa Enterprise Group's Days Payable too high?
Ginwa Enterprise Group's current Days Payable of 22.60 is 62% below median its 10-year median of 59.69. Over the past 10 years, this metric has ranged from a low of 39.21 to a high of 85.82. The Drug Manufacturers industry median Days Payable is 90.61. Ginwa Enterprise Group's value of 22.60 is 75.1% below this industry median. Based on the distribution chart, Ginwa Enterprise Group ranks #511 out of 922 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Ginwa Enterprise Group has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ginwa Enterprise Group's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ginwa Enterprise Group ranks #511 out of 922 companies for Days Payable. This places Ginwa Enterprise Group in the lower half of its industry. The industry median Days Payable is 90.61. Ginwa Enterprise Group's value of 22.60 is 75.1% below this benchmark. Historically, Ginwa Enterprise Group's own Days Payable has ranged from 39.21 to 85.82 over the past decade. While the company's 10-year median is 59.69 vs. the industry median of 90.61, Ginwa Enterprise Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.61, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ginwa Enterprise Group's current Days Payable of 22.60 is 75.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ginwa Enterprise Group and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ginwa Enterprise Group's current Days Payable is 22.60, which is 62% below median its own 10-year median of 59.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginwa Enterprise Group stock overvalued right now?
Based on GuruFocus' analysis, Ginwa Enterprise Group (SHSE:600080) is currently considered Possible Value Trap. The stock's GF Value™ is ¥7.53, compared to a current price of ¥4.94 — trading 34.4% below its estimated fair value. The current Days Payable is 22.60, which is 62% below median its 10-year median of 59.69 and 75.1% below the Drug Manufacturers industry median of 90.61. Ginwa Enterprise Group's overall GF Score™ is 47/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Ginwa Enterprise Group (SHSE:600080), the current Days Payable is 22.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ginwa Enterprise Group (SHSE:600080) Overvalued in 2026?
Based on GuruFocus' analysis, Ginwa Enterprise Group stock appears to be undervalued.
The current stock price of ¥4.94 is trading 34.4% below its estimated GF Value™ of ¥7.53.
GuruFocus considers Ginwa Enterprise Group to be Possible Value Trap.
Key valuation signals for SHSE:600080:
Days Payable: 22.60 (62% below median its 10-year median of 59.69)
GF Value™: ¥7.53 vs. price of ¥4.94 (34.4% below fair value)
Industry Position: 75.1% below the Drug Manufacturers median (#511 of 922)
No single metric tells the full story. See the SHSE:600080 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ginwa Enterprise Group Inc operates in the pharmaceutical industry. The main business is the research and development, production, and sales of drugs, and the product line covers chemical drugs, Chinese patent medicines, raw materials, and health products. The dosage forms include tablets, capsules, granules, powders, mixtures, oral solutions, syrups, external solutions, and more than 100 varieties and specifications.
47GF Score
Get the complete analysis for SHSE:600080
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600080 has been successfully added to your 
